pharmaphorum

SEPTEMBER 22, 2022

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s driving the development of new influenza and SARS-CoV-2 vaccines that attack T-cells, providing a long-lasting effect. The technology.

Vaccines 97

Vaccines Immunization 97

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunization Documentation 111

pharmaphorum

DECEMBER 6, 2022

5-adapted bivalent COVID-19 vaccine for children 6 months through 4 years of age to the FDA as a third 3-µg-dose in a three-dose-primary series, following two 3-µg-doses of the original vaccine. It is thought the updated vaccine might help to prevent severe illnesses and hospitalisation. 5-adapted bivalent vaccine.

Vaccines 105

Vaccines FDA Immunization 105

Druggist

AUGUST 8, 2020

It is expected to be that demand for flu vaccination service will be high this year. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64. This post is a summary of essential information about flu season 2020 and flu vaccination 2020/2021.

Vaccines 98

Vaccines Community Pharmacies Immunization Nursing Homes 98

Pharmaceutical Technology

MAY 25, 2023

A new vaccine developed by the Serum Institute of India to fight meningococcal disease could help eliminate meningitis across Africa. The results from a trial, published in The New England Journal of Medicine , found the vaccine was associated with a strong immune response and good safety profile. for serogroup W to 20.5

Vaccines 78

Vaccines Immunization 78

Druggist

AUGUST 8, 2020

It is expected to be that demand for flu vaccination service will be high this year. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64. This post is a summary of essential information about flu season 2020 and flu vaccination 2020/2021.

Health and Personal Care Stores 98

Health and Personal Care Stores Vaccines Community Pharmacies Immunization 98

pharmaphorum

JULY 6, 2021

Nina Garrett, R&D director at Abingdon Health discusses the key role antibody testing is playing in the pandemic and how an integrated approach with vaccines could help normal life resume. Millions of tests for COVID-19 are taken worldwide every day, as they become an increasingly important tool for our return to normality. ” . .

Immunization 111

Immunization Vaccines 111

pharmaphorum

JANUARY 10, 2023

Since then, the two partners have developed multiple AI-based applications including a platform for selecting neoantigens for use in individualised cancer vaccines and an early warning system for high risk SARS-CoV-2 variants based on how well they can evade the immune system and their transmissibility.

Immunization 116

Immunization Vaccines 116

Hospital Pharmacy Europe

OCTOBER 2, 2024

Pharmacist Dr João Gonçalves PhD considers the real-world evidence of a recent study demonstrating the feasibility and efficacy of a personalised peptide vaccine for glioblastoma – one of the most malignant primary brain tumours in adults. The median overall survival (OS) for the entire cohort was 31.9

Vaccines 52

Vaccines Immunization Chemotherapy Hospitals 52

pharmaphorum

DECEMBER 21, 2020

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.

Vaccines 111

Vaccines Immunization 111

The Checkup by Singlecare

MAY 6, 2024

Gardasil 9 is a brand-name vaccine used to protect against nine types of human papillomavirus (HPV). So, who should get the HPV vaccine, and what is the Gardasil 9 dosing schedule? Who is the HPV vaccine for? This vaccine is routine and recommended for everyone, all genders, ages 9–26,” says Christina M. Madison, Pharm.D.

Vaccines 96

Vaccines Insurance Immunization FDA 96

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 97

Immunization Vaccines Communication Labelling 97

pharmaphorum

NOVEMBER 26, 2020

BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDeep to deploy artificial intelligence and machine learning across its business.

Vaccines 105

Vaccines Immunization 105

pharmaphorum

SEPTEMBER 22, 2021

Its lead project is a T-cell receptor (TCR)-like antibody against an HLA molecule associated with intracellular protein NKG2A, an immune checkpoint. Abexxa will form part of its broad push into immuno-oncology, focused on cancer vaccines, oncolytic viruses and T-cell engagers, amongst other treatment strategies.

Vaccines 92

Vaccines Immunization 92

pharmaphorum

MARCH 9, 2021

SARS-CoV-2 is likely to stay endemic in the human population for the foreseeable future, ExeVir noted, with variants capable of evading immunity the most likely cause of the disease in the future as global vaccination programmes begin to take effect. Ablynx, which is now a subsidiary of Sanofi following a $4.8

Immunization 98

Immunization Vaccines FDA 98

pharmaphorum

JULY 9, 2021

The EU medicines regulator has said that there is some evidence to suggest a possible link between mRNA-based vaccines for COVID-19 and rare cases of heart inflammation. . Myocarditis is generally the result of a viral infection, so could be unrelated to the mRNA vaccines, particularly as neither of them contain any live virus.

Vaccines 105

Vaccines Labelling FDA Immunization 105

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

pharmaphorum

JUNE 15, 2022

Cytokines have long been investigated for their potential as cancer treatments – selectively stimulate tumour-fighting immune cells – with varying levels of success. The company came to Boehringer’s attention in 2019, when it took part in the drugmaker’s BI Innovation Prize competition.

Immunization 98

Immunization Vaccines 98

European Pharmaceutical Review

DECEMBER 22, 2022

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Vaccines 116

Vaccines Immunization Hospitals 116

BuzzRx

SEPTEMBER 12, 2022

There are two types of meningococcal vaccines available in the United States. Please keep reading to learn more about these vaccines, including their uses, benefits, and side effects. Meningococcal disease occurs when these bacteria overcome the body’s immune system and causes illnesses. What is meningococcal disease?

Vaccines 52

Vaccines Immunization 52

STAT

MARCH 6, 2023

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine.

Vaccines 98

Vaccines FDA Immunization Chemotherapy 98

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

pharmaphorum

FEBRUARY 3, 2021

Dr Jennifer Harbottle, senior scientist in the R&D Base Editing team of PerkinElmer’s Horizon Discovery business, looks at progress made in the realms of biotechnology and next-generation diagnostics, vaccines and therapeutics, including the application of CRISPR-Cas9 gene editing in developing and refining cell therapies.

Immunization 98

Immunization Vaccines 98

pharmaphorum

APRIL 27, 2021

Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results showing its experimental malaria shot could be around 77% effective. Vaccine efficacy was 74% and 77% in the low and high dose adjuvant group, respectively.

Vaccines 52

Vaccines Immunization 52

pharmaphorum

JANUARY 13, 2022

Others include a partnership between Biogen and Sangamo and Eli Lilly’s $1 billion takeover of Prevail in 2020, as well as a now-defunct alliance between AbbVie and Voyager in 2019, based on gene therapy approaches to target the rogue protein.

Immunization 98

Immunization Vaccines 98

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

Vaccines 40

Vaccines Immunization Packaging Pharmaceutical Companies 40

pharmaphorum

FEBRUARY 25, 2021

The first trial showed that it could increase levels of Treg cells thought to be involved in dampening down immune responses. That includes deals to buy OncoImmune and its COVID-19 and GvHD candidate CD24Fc and COVID-19 vaccine developer Themis last year, and the $773 million takeover of Tilos Therapeutics in 2019.

Immunization 71

Immunization Vaccines 71

pharmaphorum

OCTOBER 12, 2022

In 2019, Del Bourgo and co-founder Julien Cottineau launched Whitelab Genomics and its AI platform dedicated to supporting the discovery and design of genomic therapies. Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. About Whitelab Genomics.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

The Checkup by Singlecare

AUGUST 6, 2024

Amgen’s Avsola, according to a press release , received FDA approval as a biosimilar to Remicade in 2019. People taking Avsola or Remicade should not receive live vaccines. According to the boxed warnings: Because they suppress the immune system, Avsola or Remicade may increase the risk of serious infections.

Vaccines 97

Vaccines FDA Insurance Insurance Coverage 97

pharmaphorum

SEPTEMBER 16, 2022

The former blockbuster – first approved back in 1998 – is still making solid sales despite losing patent protection, with AZ booking $410 million from the drug last year, but are expected to drop sharply once Beyfortus and vaccines for RSV prevention reach the market. Both vaccines are also being tested in older adults.

Vaccines 59

Vaccines Immunization 59

Pharma Marketing Network

JANUARY 20, 2021

Regarding OWS’s support for vaccine development, Dr Slaoui noted that 5 of the 6 vaccines selected (from a total of 94 programs) are currently in phase 3 development or approved. The response to this crisis has “transformed the vaccine industry.”.

Vaccines 52

Vaccines Immunization Communication 52

The Checkup by Singlecare

MAY 23, 2024

There are lots of ways, from offering diabetes medication management sessions, immunizations, or even diabetes education for patients. A 2019 study aimed to assess whether a telephone-based pharmacist intervention could improve A1C in patients with poorly controlled diabetes through negotiated interviewing and shared decision-making.

Vaccines 52

Vaccines Immunization Medical Records Dosage 52

Pharmaceutical Technology

NOVEMBER 22, 2022

Vaccines are our number one weapon in the fight against infectious diseases, but their development has historically involved a long and complex process taking up to a decade. Before COVID-19, Merck held the record for the fastest modern vaccine ever developed. mRNA’s potential for rapid vaccine delivery.

Vaccines 52

Vaccines Immunization FDA 52

pharmaphorum

AUGUST 22, 2022

“Effectively, they create antibodies that can train one’s immune system to go after a specific cancer cell. ” Moderna has also created a personalised cancer vaccine, a similar idea where the vaccine is built against the specific cancer one has in the body. It could completely change how we treat cancers.”

Vaccines 102

Vaccines Chemotherapy Immunization 102

The People's Pharmacy

MAY 29, 2023

The virus hides for decades and when the immune system is no longer able to keep it at bay the virus can cause an extremely painful skin rash that can last for weeks. When the immune system weakens, the virus can be reactivated and cause a rash. That is to say it can enhance the immune systems ability to fight off certain viruses.

Immunization 72

Immunization Labelling Pharmaceutical Companies Pharmaceutical Companies 72

PQA

DECEMBER 15, 2022

Our work to develop pharmacy performance measures accelerated in 2019 at the request of PQA member organizations, especially community and specialty pharmacies, and in response to growing interest from Congress and the administration. Immunization Authority – PQA has prioritized pharmacy performance measure concepts related to immunizations.

Immunization 40

Immunization Vaccines Specialty Pharmacies Communication 40

ISPE

OCTOBER 28, 2022

The conference focused on the ongoing development and growth in these technologies, and featured speakers on a broad range of topics, including advanced manufacturing and how lessons learned from COVID-19 vaccine development can apply to biologics development. Also having enough glass vials to put the vaccines in!

Vaccines 52

Vaccines FDA Immunization 52